Europe Cancer Tissue Diagnostics Market to 2027 - Regional Analysis and Forecasts by Test Type (Immunohistochemical Tests and In Situ Hybridization Tests), and Country
Publication Month: Oct 2019
Report Code: TIPRE00006840 No. of Pages: 137 Category: Biotechnology Status: Published
Listen Report :
Cancer Tissue Diagnostics market in Europe is expected to grow from US$ 512.73 Mn in the year 2018 and is expected to reach US$ 830.28 Mn by 2027 growing at a CAGR of 5.8% over the forecast period.
The growth of the market is driven by the factors such as increasing number of cancer cases and rising geriatric population. On the other hand, high cost of cancer diagnostics in some of the European countries is limiting the growth of market is likely to have a negative impact on the growth of the market in the coming years.
Cancer is among the leading cause of deaths across Europe globe and is profoundly affecting the quality of life. Thus, cancer will be a burden on society if not diagnosed and treated on time. According to the World Health Organization in 2018, approximately 9.6 million deaths across the globe were due to cancer. Additionally, cancer is found to be commonly prevalent in European countries as well. As per the Cancer Research UK, in 2016, around 163,444 deaths in the UK were due to cancer.
The World Health Organization (WHO) also reported that with over 3.7 million new cases and 1.9 million deaths each year, cancer is the second most important cause of morbidity and death in Europe. Moreover, Europe comprises of one-eighth of the total world population, however approximately a quarter of global cancer cases with 3.7 million new patients are from Europe, suggesting high incidence rate of cancer in the region. Furthermore, the data also suggests that 40% of these cancer cases are preventable with appropriate diagnosis at early stages and correct treatment and medication.
The Spain Cancer Tissue Diagnostics market is expected to grow at highest rate during the forecast period owing to various cancer research studies undergoing in the country, increasing number of cancer patients in the country, and various solutions undertaken to reduce the financial burden due to cancer on the country. Moreover, the country also is the fastest growing among other European countries owing to the increasing medical tourism flourishing in Spain.
Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
EUROPE CANCER TISSUE DIAGNOSTICS – MARKET SEGMENTATION
By Test Type
- Immunohistochemical Tests
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Stomach Cancer
- Others
- In Situ Hybridization Tests
- Breast Cancer
- Lung Cancer
- Bladder Cancer
- Others
By Country
- France
- Germany
- UK
- Italy
- Spain
Companies Mentioned
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Abbott
- Enzo Life Sciences, Inc.
- Agilent Technologies, Inc.
- Cancer Genetics Inc.
- Merck KGaA (Sigma-Aldrich Co. LLC)
- Danaher
- Abcam plc.
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. Europe Cancer Tissue Diagnostics Market – Key Takeaways
3. Europe Cancer Tissue Diagnostics Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Cancer Tissue Diagnostics Market – By Test Type
3.2.2 Europe Cancer Tissue Diagnostics Market – By Country
3.3 PEST Analysis
3.3.1 Europe – PEST Analysis
4. Europe Cancer Tissue Diagnostics Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Number of Cancer Cases
4.1.2 Increasing Geriatric Population
4.2 Key Market Restraint
4.2.1 High Cost of Cancer Diagnostics
4.3 Key Market Opportunities
4.3.1 Rising Healthcare Expenditure in Europe
4.4 Future Trends
4.4.1 Adoption of Personalized Medicine
4.5 Impact Analysis
5. Cancer Tissue Diagnostics Market – Europe Analysis
5.1 Europe Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis
5.2 Performance Of Key Players
5.3 Positioning of Key Players
6. Europe Cancer Tissue Diagnostics Market Analysis –By Test Type
6.1 Overview
6.2 EUROPE Cancer Tissue Diagnostics MARKET, BY Test Type, 2017 & 2027 (%)
6.3 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027, By Test Type (US$ Mn)
6.4 Europe Immunohistochemical Tests Market
6.4.1 Overview
6.4.2 Europe Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.3 Breast Cancer Market
6.4.3.1 Overview
6.4.3.2 Breast Cancer Market Revenue and Forecast to 2027 (US$ Mn)
6.4.4 Colorectal Cancer Market
6.4.4.1 Overview
6.4.4.2 Colorectal Cancer Market Revenue and Forecast to 2027 (US$ Mn)
6.4.5 Prostate Cancer Market
6.4.5.1 Overview
6.4.5.2 Prostate Cancer Market Revenue and Forecast to 2027 (US$ Mn)
6.4.6 Stomach Cancer Market
6.4.6.1 Overview
6.4.6.2 Stomach Cancer Market Revenue and Forecast to 2027 (US$ Mn)
6.4.7 Others Market
6.4.7.1 Overview
6.4.7.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
6.5 In Situ Hybridization Tests Market
6.5.1 Overview
6.5.2 In Situ Hybridization Tests Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3 Breast Cancer Market
6.5.3.1 Overview
6.5.3.2 Breast Cancer Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4 Lung Cancer Market
6.5.4.1 Overview
6.5.4.2 Lung Cancer Market Revenue and Forecast to 2027 (US$ Mn)
6.5.5 Bladder Cancer Market
6.5.5.1 Overview
6.5.5.2 Bladder Cancer Market Revenue and Forecast to 2027 (US$ Mn)
6.5.6 Others Market
6.5.6.1 Overview
6.5.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
7. Europe Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
7.1 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027
7.1.1 Europe Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.2 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.2.1 Europe Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.2.2 Europe In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.3 Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
7.1.4 UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.4.1 UK Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.4.2 UK Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.4.2.1 UK Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.4.2.2 UK In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.5 Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.5.1 Germany Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.5.2 Germany Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.5.2.1 Germany Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.5.2.2 Germany In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.6 France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.6.1 France Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.6.2 France Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.6.2.1 France Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.6.2.2 France In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.7 Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.7.1 Italy Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.7.2 Italy Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.7.2.1 Italy Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.7.2.2 Italy In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.8 Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.8.1 Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.8.2 Spain Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.8.2.1 Spain Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.8.2.2 Spain In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8. Cancer Tissue Diagnostics Market – Industry Landscape
8.1 Overview
8.2 Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019
8.3 Organic Growth Strategies
8.3.1 Overview
8.4 Organic Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019 (%)
8.4.1 Product Launches
8.4.1.1 Recent Product Launches By Players In The Cancer Tissue Diagnostics Market
8.4.2 Product Approvals
8.4.2.1 Recent Product Approvals By Players In The Cancer Tissue Diagnostics Market
8.4.3 Expansion & Other Activities
8.4.3.1 Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
8.4.4 Product Enhancements
8.4.4.1 Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
8.5 Inorganic Growth Strategies
8.5.1 Overview
8.6 Inorganic Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019 (%)
8.6.1 Agreements
8.6.1.1 Recent Agreements By Players In The Cancer Tissue Diagnostics Market
8.6.2 Partnerships & Collaborations
8.6.2.1 Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
8.6.3 Acquisitions
8.6.3.1 Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market
9. Cancer Tissue Diagnostics Market–Key Company Profiles
9.1 Bio-Rad Laboratories, Inc.
9.1.1 Key Facts
9.1.2 Business Description
9.1.3 Financial Information
9.1.4 Product Portfolio
9.1.5 SWOT Analysis
9.1.6 Key Developments
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Key Facts
9.2.2 Business Description
9.2.3 Financial Information
9.2.4 Product Portfolio
9.2.5 SWOT Analysis
9.2.6 Key Developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 Key Facts
9.3.2 Business Description
9.3.3 Financial Overview
9.3.4 Product Portfolio
9.3.5 SWOT Analysis
9.3.6 Key Developments
9.4 Abbott
9.4.1 Key Facts
9.4.2 Business Description
9.4.3 Financial Overview
9.4.4 Product Portfolio
9.4.5 SWOT Analysis
9.4.6 Key Developments
9.5 Enzo Biochem Inc.
9.5.1 Key Facts
9.5.2 Business Description
9.5.3 Financial Overview
9.5.4 Product Portfolio
9.5.5 SWOT Analysis
9.5.6 Key Developments
9.6 Agilent Technologies, Inc.
9.6.1 Key Facts
9.6.2 Business Description
9.6.3 Financial Overview
9.6.4 Product Portfolio
9.6.5 SWOT Analysis
9.6.6 Key Developments
9.7 Cancer Genetics Inc.
9.7.1 Key Facts
9.7.2 Business Description
9.7.3 Financial Overview
9.7.4 Product Portfolio
9.7.5 SWOT Analysis
9.7.6 Key Developments
9.8 Merck Kgaa (Sigma-Aldrich)
9.8.1 Key Facts
9.8.2 Business Description
9.8.3 Financial Overview
9.8.4 Product Portfolio
9.8.5 SWOT Analysis
9.8.6 Key Developments
9.9 Abcam Plc.
9.9.1 Key Facts
9.9.2 Business Description
9.9.3 Financial Overview
9.9.4 Product Portfolio
9.9.5 SWOT Analysis
9.9.6 Key Developments
9.10 Danaher
9.10.1 Key Facts
9.10.2 Business Description
9.10.3 Financial Information
9.10.4 Product Portfolio
9.10.5 SWOT Analysis
9.10.6 Key Developments
10. Appendix
10.1 About The Insight Partners
10.2 Glossary Of Terms
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Primary Research
LIST OF TABLES
Table 1. Europe Cancer Tissue Diagnostics market Revenue And Forecasts to 2027, By test type (US$ Mn)
Table 2. Europe Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 3. Europe Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 4. Europe In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 5. UK Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 6. UK Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 7. UK In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 8. Germany Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 9. Germany Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 10. Germany In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 11. France Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 12. France Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 13. France In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 14. Italy Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 15. Italy Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 16. Italy In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 17. Spain Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 18. Spain Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 19. Spain In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 20. Recent Product Launches in the Cancer Tissue Diagnostics Market
Table 21. Recent product Approvals in the Cancer Tissue Diagnostics Market
Table 22. Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
Table 23. Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
Table 24. Recent Agreements By Players In The Cancer Tissue Diagnostics Market
Table 25. Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
Table 26. Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market
Table 27. Glossary of Terms, Cancer Tissue Diagnostics market
LIST OF FIGURES
Figure 1. Spain Cancer Tissue Diagnostics Market, Revenue (US$ Mn), By 2018 & 2027
Figure 2. Europe Cancer Tissue Diagnostics Market By Test Type Share (%), 2018
Figure 3. Cancer Tissue Diagnostics Market Segmentation
Figure 4. Europe PEST Analysis
Figure 5. Cancer Tissue Diagnostics Market Impact Analysis Of Drivers & Restraints
Figure 6. Europe Cancer Tissue Diagnostics Market – Revenue Forecasts And Analysis – 2017- 2027
Figure 7. Market Positioning Of Key Player In Europe Cancer Tissue Diagnostics Market
Figure 8. Europe Cancer Tissue Diagnostics Market, By Test Type, 2017 & 2027 (%)
Figure 9. Europe Immunohistochemical Tests Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 10. Breast Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 11. Colorectal Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. Prostate Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 13. Stomach Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 14. Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 15. In Situ Hybridization Tests Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 16. Breast Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 17. Lung Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 18. Bladder Cancer Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. Europe Cancer Tissue Diagnostics Market Revenue Overview, By Country, 2018 (US$ MN)
Figure 21. Europe Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. Europe Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027, By Country (%)
Figure 23. UK Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. Germany Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 25. France Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Italy Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Spain Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019
Figure 29. Organic Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019 (%)
Figure 30. Inorganic Developments In The Cancer Tissue Diagnostics Market, 2016-2019(%)
The List of Companies
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Abbott
- Enzo Life Sciences, Inc.
- Agilent Technologies, Inc.
- Cancer Genetics Inc.
- Merck KGaA (Sigma-Aldrich Co. LLC)
- Danaher
- Abcam plc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer tissue diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe cancer tissue diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.